Skip to content
Search

Latest Stories

India-UK sign pact to collaborate on cancer research

India and the UK signed a Memorandum of Understanding (MoU) Wednesday for collaboration in cancer research, the Ministry of Science and Technology said in a statement.

The pact between the Department of Biotechnology (DBT) and the Cancer Research UK (CRUK) for the India-UK Cancer Research Initiative was signed here for collaboration for the next five years.


Both CRUK and DBT will invest £5million each in this five-year pilot project, and seek further investment from other potential funding partners.

The India-UK Cancer Research Initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer patients by bringing together leading Indian and UK experts in clinical research, demographic research, new technologies and physical sciences, the statement said.

"The initiative will provide funding to develop new research alliances and undertake impactful research to enable significant progress against cancer outcomes," the statement added.

This is a follow-up to the joint statement issued by the premiers of India and UK during the visit of Prime Minister Narendra Modi to the UK in April.

Modi had then stated, "As thriving democracies, we share a desire to work closely together and with all who share our objective to support a rules-based international order that upholds agreed international norms, global peace and stability.

"Together the UK and India are a force for good in an uncertain world. We are sharing our experience and knowledge to tackle global challenges. India's Department of Biotechnology (DBT) and Cancer Research UK propose to launch a £10 million bilateral research initiative which will focus on low cost approaches to cancer treatment."

Speaking at the launch of this initiative, Secretary of DBT, Renu Swarup, said, "Cancer is a global epidemic that requires radically new approaches through inter-disciplinary and multi-national efforts. The India-UK Cancer Research Initiative will provide a catalysing platform for scientists and researchers in the UK and India to co-create solutions for affordable cancer care that improve cancer outcomes around the globe."

On the occasion, Nick Grant, Cancer Research UK's executive director of international partnerships, spoke in the importance of the research partnership saying no country escapes the impact of cancer.

More For You

John Xavier

In 2019, Xavier founded London Baron Limited, with Manavatty as its flagship product.

John Xavier

How John Xavier turned Kerala’s traditional arrack into Manavatty — a rising UK spirits brand

Highlights

  • Manavatty now available in over 250 off-licence shops across the UK and expanding to 20 countries.
  • Brand won bronze at London Spirits Competition 2025 and Spirit Bronze 2025 at International Wine and Spirit Competition.
  • Scottish National Party auctioned signed Manavatty bottles at Edinburgh for party fundraising.
When Scotland's first minister John Swinney signed a bottle of Manavatty at the Scottish National Party convention in Edinburgh on (November 15), it marked an extraordinary milestone for an entrepreneur who had resurrected a spirit banned in his native Indian state.
With Scotland's SNP elections approaching in 2026, the party selected Manavatty for their traditional fundraising auction, a recognition that few immigrant-founded brands achieve.

"It's a tradition for the SNP political party to keep a product at an auction and take the funds for party welfare," explains John Xavier, the man behind this unlikely success story.

John Xavier Manavatty was selected for SNP's traditional fundraising auctionJohn Xavier

Keep ReadingShow less